PNC-27
Why it is for you
The straight answer is that this is laboratory cancer biology and almost certainly not for you. It sits in this library because it is sold under this name and because somebody searching deserves an accurate account of what it is rather than a sales page. The root-cause picture it belongs to is oncology: a cancer cell displaying HDM-2 in its membrane, in a person under the care of a cancer team. If you are facing a cancer diagnosis, the people to speak to are your oncologists, and the question to ask them is what is open to you, including studies you might join. Nothing in the rest of this library substitutes for that conversation, and nothing here should delay it. The peptides that do have a place alongside cancer care are the repair and recovery ones, and those are decisions for your oncology team to make with you, because some of them act on growth signalling.
Sources
Read the original sources
- Ex vivo efficacy of PNC-27 in the treatment of patient-derived epithelial ovarian cancer (Abstract · checked 2026-10-13)
- Poptosis or peptide-induced transmembrane pore formation: a novel way to kill cancer cells without affecting normal cells (Summary · checked 2026-10-13)
- PNC-28, a p53-derived peptide cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo (Abstract · checked 2026-10-13)